Kling Biotherapeutics to Present Key Applications for its Primary B-Cell Immortalization, Screening and Antibody Optimization Platform Technologies at PEGS Europe

Seaking Alpha

Seeking Alpha / Seaking Alpha 1 Views

Kling-Select is a uniquely promising approach to identifying novel targets and therapeutic antibodies from human and animal sources Kling-Evolve enables highly rapid selection of effective neutralizing antibodies against viral escape variants AMSTERDAM, Oct. 31, 2024 /PRNewswire/ -- Kling...

Comments